The peptide CGRP is thought to be an agonist at a number of receptors including its own as well as those for adrenomedullin and amylin. CGRP is thought to act through its own receptors if it is antagonized by the truncated peptide CGRP 8-37 although this assumes the specificity of the antagonist.
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The subdivision of CGRP receptors by Quirion and colleagues into two types was based on use of a "selective" agonist, Cys(ACM 2,7 )CGRP, and on truncated fragments of CGRP itself which were antagonists with varying potency in different systems. Most recently CRLR and RAMPs have been identified and provide a different perspective on CGRP receptors. It appears difficult to reconcile all these findings. Some of the issues include:
• •
To what extent may the original CGRP1/2 subdivision be influenced by species differences in receptors? 
